Case Report: Avelumab and ruxolitinib to manage polycythemia vera and secondary metastatic Merkel cell carcinoma: a possible successful combination

We describe a case of second primary malignancy in a 65-year-old patient affected by polycythemia vera treated with the JAK 1/2 inhibitor ruxolitinib. The latter is recognized as a risk factor for the onset of non-melanoma skin cancers in many retrospective and perspective studies, but the concomita...

Descripción completa

Detalles Bibliográficos
Autores principales: Masucci, Chiara, Passucci, Mauro, Scalzulli, Emilia, Carmosino, Ida, Capriata, Marcello, Costa, Alessandro, Ielo, Claudia, Martelli, Maurizio, Breccia, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282638/
https://www.ncbi.nlm.nih.gov/pubmed/37350945
http://dx.doi.org/10.3389/fonc.2023.1212638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282638/
https://www.ncbi.nlm.nih.gov/pubmed/37350945
http://dx.doi.org/10.3389/fonc.2023.1212638

Ejemplares similares